Astellas Pharma OAB drug gets Japanese approval
Discovered and developed by Astellas, Betanis tablet improves urine collection function by activating ß3-adrenoceptor selectively on the bladder’s smooth muscles, relaxing bladder and improving OAB disorder. Betanis tablet
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.